Evidence map›Paper›PMID 25528446›Full record

ArticleOrphanet journal of rare diseases2014

Oxidative stress and mitochondrial dysfunction in Kindler syndrome.

Elisabeth Zapatero-Solana, Jose Luis García-Giménez, Sara Guerrero-Aspizua, Marta García, Agustí Toll, Eulalia Baselga, Maria Durán-Moreno, Jelena Markovic, Jose Manuel García-Verdugo, Claudio J Conti and 4 more

Open access · goldAbstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Observational
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Elisabeth Zapatero-SolanaCentre for Biomedical Network Research on Rare Diseases (CIBERER), ISCIII, Valencia, Spain. elisabet.zapatero@ciemat.es.
Jose Luis García-GiménezCentre for Biomedical Network Research on Rare Diseases (CIBERER), ISCIII, Valencia, Spain. j.luis.garcia@uv.es.
Sara Guerrero-AspizuaCentre for Biomedical Network Research on Rare Diseases (CIBERER), ISCIII, Valencia, Spain. sguerrer@ing.uc3m.es.
Marta GarcíaCentre for Biomedical Network Research on Rare Diseases (CIBERER), ISCIII, Valencia, Spain. mgdiez@ing.uc3m.es.
Agustí TollServei de Dermatologia, Hospital del Mar, Parc de Salut Mar, Cancer Research Program, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain. 93828@parcdesalutmar.cat.
Eulalia BaselgaDepartment of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. dra.baselga@gmail.com.
Maria Durán-MorenoLaboratorio de Neurobiología Comparada, Instituto Cavanilles, Universidad de Valencia, CIBERNED, Valencia, Spain. maria.duran@uv.es.
Jelena MarkovicCentre for Biomedical Network Research on Rare Diseases (CIBERER), ISCIII, Valencia, Spain. jelena.markovic@uv.es.
Jose Manuel García-VerdugoLaboratorio de Neurobiología Comparada, Instituto Cavanilles, Universidad de Valencia, CIBERNED, Valencia, Spain. j.manuel.garcia@uv.es.
Claudio J ContiDepartment of Bioengineering, Universidad Carlos III de Madrid (UC3M), Madrid, Spain. cconti@ing.uc3m.es.
Cristina HasDepartment of Dermatology, Medical Centre-University of Freiburg, Freiburg, Germany. cristina.has@uniklinik-freiburg.de.
Fernando LarcherCentre for Biomedical Network Research on Rare Diseases (CIBERER), ISCIII, Valencia, Spain. fernando.larcher@ciemat.es.
Federico V PallardóCentre for Biomedical Network Research on Rare Diseases (CIBERER), ISCIII, Valencia, Spain. federico.v.pallardo@uv.es.
Marcela Del RioCentre for Biomedical Network Research on Rare Diseases (CIBERER), ISCIII, Valencia, Spain. marcela.delrio@uc3m.es.
Centre for Biomedical Network Research on Rare Diseases · ESUniversitat de València · ESHospital de Sant Pau · ESHospital Universitario Fundación Jiménez Díaz · ESParc de Salut · ESUniversity Medical Center Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKindler Syndrome (KS) is an autosomal recessive skin disorder characterized by skin blistering, photosensitivity, premature aging, and propensity to skin cancer. In spite of the knowledge underlying cause of this disease involving mutations of FERMT1 (fermitin family member 1), and efforts to characterize genotype-phenotype correlations, the clinical variability of this genodermatosis is still poorly understood. In addition, several pathognomonic features of KS, not related to skin fragility such as aging, inflammation and cancer predisposition have been strongly associated with oxidative stress. Alterations of the cellular redox status have not been previously studied in KS. Here we explored the role of oxidative stress in the pathogenesis of this rare cutaneous disease.

methodsPatient-derived keratinocytes and their respective controls were cultured and classified according to their different mutations by PCR and western blot, the oxidative stress biomarkers were analyzed by spectrophotometry and qPCR and additionally redox biosensors experiments were also performed. The mitochondrial structure and functionality were analyzed by confocal microscopy and electron microscopy.

resultsPatient-derived keratinocytes showed altered levels of several oxidative stress biomarkers including MDA (malondialdehyde), GSSG/GSH ratio (oxidized and reduced glutathione) and GCL (gamma-glutamyl cysteine ligase) subunits. Electron microscopy analysis of both, KS skin biopsies and keratinocytes showed marked morphological mitochondrial abnormalities. Consistently, confocal microscopy studies of mitochondrial fluorescent probes confirmed the mitochondrial derangement. Imbalance of oxidative stress biomarkers together with abnormalities in the mitochondrial network and function are consistent with a pro-oxidant state.

conclusionsThis is the first study to describe mitochondrial dysfunction and oxidative stress involvement in KS.

Indexed as

AdolescentAged, 80 and overBlisterCells, CulturedChildChild, PreschoolEpidermolysis BullosaFemaleHumansKeratinocytesMaleMiddle AgedMitochondriaOxidative StressPeriodontal DiseasesPhotosensitivity Disorders

Identifiers

PMID25528446
PMCPMC4302591
OpenAlexW2044024978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.